"Chimney Technique" for Recurrent Mitral Regurgitation Post-transapical Transcatheter Aortic Valve Implantation and Transcatheter Edge-to-edge Repair
Pengxiong Zhu,Bangde Xue,Qi Zhang,Jun Liu
DOI: https://doi.org/10.1016/j.xjtc.2024.06.015
2024-01-01
JTCVS Techniques
Abstract:Central MessageThe chimney technique is a key to ensuring successful mitral bioprosthesis implantation in patients with recurrent mitral regurgitation post-TAVI and TEER.See Commentary on page XXX. The chimney technique is a key to ensuring successful mitral bioprosthesis implantation in patients with recurrent mitral regurgitation post-TAVI and TEER. See Commentary on page XXX. The investigation was approved by the institutional review board (IRB-2024-068; approval date: May 6, 2024), and the patient gave written informed consent for publication. An 81-year-old man had recurrent exertional chest discomfort and dyspnea over a year, and orthopnea at night for a month. His symptoms included lower limb edema and palpitations. Echocardiography revealed moderate to severe aortic regurgitation, anterior mitral leaflet prolapse with severe regurgitation, and severe tricuspid regurgitation. An electrocardiogram confirmed atrial fibrillation. Considering his advanced age and European System for Cardiac Operative Risk Evaluation II score of 11.33%, a simultaneous transapical transcatheter aortic valve implantation (TA-TAVI) and TA transcatheter edge-to-edge repair (TA-TEER) was chosen. The surgery involved a 4-cm incision at the left chest's fifth intercostal space to access the apex, enabling the successful implantation of a 29-mm J-valve prosthesis (JieCheng Medical Technology Co) and 2 MVC-IIIf Valve Clamps (Hanyu Medical Technology). Postoperatively, the patient experienced symptom relief. Echocardiography confirmed optimal prosthetic aortic valve function showing a peak flow velocity of 1.7 meter per second and a peak gradient of 12 mm Hg, without any paravalvular leakage or regurgitation. The mitral valve demonstrated a peak flow velocity of 1.5 meter per second and a peak gradient of 7 mm Hg with mild regurgitation. Follow-up at 1, 3, and 6 months postoperation confirmed good valve function. Eight months after surgery, the patient experienced recurrent symptoms. Echocardiography showed the aortic valve functioning well, but revealed the left valve clamp had detached from the posterior mitral leaflet, a condition often referred to as single leaflet device attachment,1Maisano F. Franzen O. Baldus S. et al.Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.J Am Coll Cardiol. 2013; 62: 1052-1061Crossref PubMed Scopus (717) Google Scholar resulting in severe mitral regurgitation with a regurgitant area of 10 cm2 (Figure 1). Preoperative coronary angiography showed the swinging valve clamp (Video 1). A second operation employed the chimney technique to implant a skirted mitral bioprosthesis. The intraoperative exploration revealed a detached valve clamp and a torn original coaptation site (Figure 2, A and B). The native mitral valve and valve clamps were excised. A composite valve graft was assembled by a 30-mm artificial blood vessel (MAQUET Holding B.V. & Co) and a 27-mm mitral bioprosthesis (Medtronic) with running 4-0 polypropylene sutures (Figure 2, C). The graft margin was trimmed to a length of approximately 1 cm to avoid kinking, leaving 1 side slightly longer (Figure 2, D). Then, the composite valve graft was implanted at the mitral position (Video 2). Postoperative enhanced computed tomography (Video 3) and echocardiography validated the chimney technique's effectiveness, confirming optimal function of the new mitral bioprosthesis and avoiding interference from the TAVI valve stent.Figure 2A, The intraoperative investigation uncovered a detached valve clamp and a ruptured original coaptation site. B, The failed valve clamp removed from the mitral valve. C, A composite valve graft was assembled by a 30-mm artificial blood vessel and a 27-mm mitral bioprosthesis with running 4-0 polypropylene sutures. D, The length of the graft margin was tailored to approximately 1 cm with 1 side left slightly longer.View Large Image Figure ViewerDownload Hi-res image Download (PPT) The management of multiple valve diseases in elderly patients poses significant challenges, especially when compounded by advanced age and comorbid conditions. The Society of Thoracic Surgeons Registry data showed that the perioperative mortality for combined aortic and mitral valve operations (9.4%) is almost 3-fold higher than for isolated aortic valve replacements.2Rankin J.S. He X. O'Brien S.M. et al.The Society of Thoracic Surgeons risk model for operative mortality after multiple valve surgery.Ann Thorac Surg. 2013; 95: 1484-1490Abstract Full Text Full Text PDF PubMed Google Scholar In this instance, an 81-year-old man with severe multivalvular disease underwent simultaneous TA-TAVI and TA-TEER. These minimally invasive procedures significantly reduced the physiological stress on the patient. This case underscores the increasing shift toward minimally invasive procedures for high-risk patients. In China, the National Medical Products Administration has approved only the J-valve for the treatment of aortic regurgitation via TAVI. Other TAVI products do not have approval for this indication. Consequently, at our center, we routinely use TA-TAVI with the J-valve for patients with aortic regurgitation, whereas TF-TAVI is employed for treating aortic stenosis. Furthermore, literature indicates that the J-valve achieves higher procedural success rates in treating aortic regurgitation compared with other transfemoral transcatheter aortic valve replacement devices.3Soong E.L. Ong Y.J. Ho J.S.Y. et al.Transcatheter aortic valve replacement for aortic regurgitation in Asians: TAVR for aortic regurgitation in Asians.AsiaIntervention. 2021; 7: 103-111Crossref PubMed Google Scholar This evidence supports our decision to use the TA route in this patient. The initial success of the TA-TAVI and TA-TEER in mitigating the patient's symptoms attests to the effectiveness of these techniques in addressing aortic and mitral regurgitations. The use of a 29-mm J-valve prosthesis and 2 MVC-IIIf Valve Clamps proved initially beneficial, achieving excellent postoperative outcomes with significant symptom alleviation and no paravalvular leakage, corroborated by follow-up echocardiography. These findings align with existing research, suggesting that TAVI and TEER can deliver favorable short-term results for elderly patients with complex valve diseases, substantially reducing the physiological stress associated with traditional open-heart surgery.4Baumgartner H. Iung B. Messika-Zeitoun D. Otto C.M. The year in cardiovascular medicine 2021: valvular heart disease.Eur Heart J. 2022; 43: 633-640Crossref Scopus (3) Google Scholar However, symptom recurrence 8 months postoperatively, marked by exertional chest discomfort and dyspnea, highlights the complexities and limitations of these procedures. The single leaflet device attachment and leaflet tear, resulting in severe regurgitation, emphasizes the need for durable device performance and highlights potential mechanical failures in transcatheter mitral valve repairs.1Maisano F. Franzen O. Baldus S. et al.Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe.J Am Coll Cardiol. 2013; 62: 1052-1061Crossref PubMed Scopus (717) Google Scholar,5Glower D. Ailawadi G. Argenziano M. et al.EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure.J Thorac Cardiovasc Surg. 2012; 143: S60-S63Abstract Full Text Full Text PDF PubMed Scopus (75) Google Scholar This complication necessitated a secondary procedure using the chimney technique to implant a skirted bioprosthesis that was strategically chosen to prevent interference from the adjacent TAVI stent, showcasing a novel solution to complications from simultaneous transcatheter valve treatments. The successful application of the chimney technique is notable. This technique not only opens up the left ventricular outflow tract but also provides a durable solution to mitigate the risk of future valve failures. By establishing an artificial annulus distanced from the TAVI stent, the procedure ensures optimal functionality of the new mitral bioprosthesis while addressing the challenges posed by the proximity of the 2 devices. Especially for a patient in his eighth decade who has already undergone 2 heart surgeries within the past year, we specifically considered the potential influence of the TAVI stent below the aortic annulus on the newly implanted mitral bioprosthesis when devising the surgical plan. We aimed to minimize the risk of early degeneration of the mitral bioprosthesis caused by this factor because a third surgery within a short period might be difficult for such a patient to endure. The outcomes align with recent studies suggesting the chimney technique as a feasible option for mitral valve replacement in challenging anatomical conditions.6Yang M. Song L. Xiao Y. Tao L. Early and mid-term outcomes of using the chimney technique in redo mitral valve replacement in patients with a small mitral annulus.J Clin Med. 2024; 13: 270Crossref Scopus (0) Google Scholar,7Parachuri V.R. Tripathy A.K. Mallikarjuna J. Bio-chimney technique for narrow mitral annulus in adults.Ann Thorac Surg. 2019; 108: e65-e67Abstract Full Text Full Text PDF Scopus (1) Google Scholar This case highlights the necessity for continuous monitoring and potential future interventions for patients undergoing complex transcatheter valve repairs or replacements. It also accentuates the evolving landscape of valvular heart disease management, where ongoing surgical innovation is crucial to enhancing patient outcomes. The authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI1NTg3YTA4YzRmMTg4NDczNGNiZWYyZGNiZDM1NjBiMyIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.izmg8DUdZhGiZaBAZy-PKOj2D8O_VSEynMJVLfhPvymxy1r10R_kZa4v6hkNP35c2lh-zY1Ojzwzft7ksLcgAx6Sn7WQSoZFeInuqCardXU6H2v6548sBFa4wCA6z1dVncHEpeQF7eIKi-kj-FENNZdQxQ5BqVEyj8QKugJTtJyUQST001ZW6eaAGe4HHPoZ78J614NxngRnlMCpvTqcaqBDu7AuNNmiAPBcxiMwKjGnZzH1pRP3qxbaUs8hQacOCJsqIFQtONZe38Bw9HIwrmUICvEriZiqDiEAwGJRQhzNRdXHXFFFS2B-E55SmlEq2oppg83JMqAJgnYJ2TNugQ Download .mp4 (1.5 MB) Help with .mp4 files Video 1Preoperative coronary angiography displayed the oscillating valve clamp moving in harmony with the cardiac cycle. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.18 MB) Help with files Video 1Preoperative coronary angiography displayed the oscillating valve clamp moving in harmony with the cardiac cycle. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiIyNzdiZDZmMTc3YjE0Yzk1Yzk3NTE5NzNkMzM2OWVjYiIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.mSNoSrK80qRYXtzcRpJ6yE8WOAeGmZsotIJJ1JVbWcwu4MqnxMIkjFf6zZGrk8_OA6vrYmYEnxIhu0Wx6VKozeoYbTLlfDRyTakSK8EFi4aoE_4fc40VEqM1JeWMOF5XWD7RFZxzqEchdBTS_5ChYJnLfAPz-geFvOAk1dJXdtP3JPKnY_DXwf2kJM38B4d3h0jaJvSG3CFiHjb-iDqE-ec-fZ15cUqhd5L8iHJuZ__lKlzGw32mNgjG8GEgRadS7DuWTcBMMCBuOSqlc0F-6bIpbwW4-Zq1gq7rvxxP9cpsoJB6XhgcQruRoy_JTtNUUEWOUoXfV_O4zEsSASj-Xg Download .mp4 (1.28 MB) Help with .mp4 files Video 2A mitral bioprosthesis was implanted using the chimney technique. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.44 MB) Help with files Video 2A mitral bioprosthesis was implanted using the chimney technique. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJkYWZiYzFlOTdlYTEzMjU2NjVmYzU5ZDI4NmQ1NjUyMSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzI0MDAwNzg0fQ.XlDENt7F6RC7DYy3yJahK1vLxmIA84f_boeR2uSH5wSOVAda9kSWFtiv_3-AvP3TvcdkTB_u3UIUYMZBy5qhbbo6VLrO2uCb7MaD-4pAJabpaR7cu2ohli3yIx1JZqFPDvzAPBKxH--1U2r9IGSVCgfyb35B4JsCe5K2iJM10P1ZvIm_UhYUwahLUGhTV5G8y74shtrg6q0ZG_xTd1q17TtoIXpPCUbNurvJSP-csY0pj23NXYP3N2QZ9MHwdutR64avMqp-PhuCUe3jDXTe-otbOg86FUnO3OAt57WOe6zjLjbsJFKavEibA0CbWqb58rbjSi5bNhGDPEmQ7_dObg Download .mp4 (4.19 MB) Help with .mp4 files Video 3Postoperative enhanced computed tomography revealed the elevated site of the mitral bioprosthesis from the original mitral annulus, avoiding interference from the transcatheter aortic valve implantation valve stent. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext. Download .jpg (.14 MB) Help with files Video 3Postoperative enhanced computed tomography revealed the elevated site of the mitral bioprosthesis from the original mitral annulus, avoiding interference from the transcatheter aortic valve implantation valve stent. Video available at: https://www.jtcvs.org/article/S2666-2507(24)00264-5/fulltext.